Pharma Exclusives Pressreleases
Thermo Fisher Scientific, South African Medical Research Council and Department of Science Innovation and Technology Announce New Training Facility to Develop Next Generation
Thursday, July 17, 2025Thermo Fisher Scientific Inc the world leader in serving science and the South African Medical Research Council SAMRC an entity of the Department of Health together with South Africas Department of Science Innovation
Bristol Myers Squibb and Pfizer Announce Direct-to-Patient Eliquis® (apixaban) Option
Thursday, July 17, 2025The Bristol Myers SquibbPfizer Alliance today announced a new directtopatient option for purchasing Eliquis apixaban via our Alliances patient resource Eliquis Support The offering provides an opportunity for uninsured underinsured
Lantern Pharma Unveils Groundbreaking AI-Powered Module to Predict Activity and Efficacy of Combination Regimens in Clinical Cancer Treatment
Wednesday, July 16, 2025Lantern Pharma Inc a pioneering artificial intelligence AI company transforming oncology drug discovery and development today announced the launch of an innovative AIpowered module within its proprietary RADR platform
Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition
Wednesday, July 16, 2025Aptar Pharma a global leader in drug delivery and active material science solutions and services today announces its acquisition of the clinical trial materials manufacturing capabilities of Mod Pharma
Merck to Initiate Phase 3 Trials for Investigational Once-Monthly HIV Prevention Pill
Tuesday, July 15, 2025Merck known as MSD outside of the United States and Canada today announced the initiation of the EXPrESSIVE Phase clinical trials evaluating the safety and efficacy of MK an investigational oncemonthly
Thermo Fisher Scientific Introduces the Oncomine Comprehensive Assay Plus on the Ion Torrent Genexus System to Help Advance the Future of Precision Medicine
Tuesday, July 15, 2025Thermo Fisher Scientific announced that the Oncomine Comprehensive Assay Plus is now available on the Ion Torrent Genexus System helping accelerate precision oncology research
Baxdrostat met the primary and all secondary endpoints in BaxHTN Phase III trial in patients with uncontrolled or treatment resistant hypertension
Monday, July 14, 2025Positive highlevel results from the BaxHTN Phase III trial showed baxdrostat at two doses mg and mg demonstrated a statistically significant and clinically meaningful reduction in mean seated systolic blood pressure SBP
Takeda Announces Positive Results from Two Pivotal Phase 3 Studies of Oveporexton (TAK-861) in Narcolepsy Type 1
Monday, July 14, 2025Takeda today announced that all primary and secondary endpoints were met in two Phase randomized doubleblind placebocontrolled studies of oveporexton TAK a potential firstinclass investigational oral orexin receptor
Bio-Techne's Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-Based Gene Therapy
Monday, July 14, 2025BioTechne Corporation today announced that its Simple Western Technology played a key role in supporting the FDA approval of ZEVASKYN prademagene zamikeracel the first autologous cellbased gene therapy for patients
Tonix Pharmaceuticals Announces Presentation of New Data on Mpox and Smallpox Vaccine Candidate TNX-801 at the Vaccine Congress 2025
Thursday, July 10, 2025Tonix Pharmaceuticals Holding Corp a fully integrated biopharmaceutical company with marketed products and a pipeline of development candidates today announced the presentation of new findings on TNX
